Summary. Intrauterine infusion of enriched bovine trophoblast protein-1 complex 
Introduction
Continued maintenance of the corpus luteum (CL) is required if maintenance of early pregnancy is to occur in cattle. Failure of a conceptus to 'signal' its presence results in release· of prostaglandin (PG) F-2a, luteolysis and resumption of ovarian cyclicity. The bovine conceptus must signal its presence by Day 15-17 of pregnancy if CL function is to be maintained (Northey & French, 1980; Betteridge et al, 1984; Dalla Porta & Humblot, 1984 Knickerbocker et al, 1986a, b) . The bovine trophoblast protein-1 complex (bTP-1), which represents a major component of bCSPs from (Bartol et al, 1985; Helmer et al, 1987) , has been identified as a putative candidate for the antiluteolytic agent in cattle. Furthermore, bTP-1 is immunologically related to ovine trophoblast protein-1 (oTP-1; Helmer et al, 1987) , which is responsible for luteal maintenance in the ewe (Godkin et al, 1984) . The bTP-1 complex consists of 7 isoelectric variants (pi = 5-5 to 5-7) of N-linked glycoproteins in two molecular weight classes; one of Mr 22 000 and high mannose content and the other of M, 24 000 and complex carbohydrate content (Helmer et al, 1987 Anthony et al, 1988 ). The present study was designed to evaluate the role of bTP-1 in extension of CL lifespan by purifying bTP-1 and testing its efficacy as an antiluteolysin when infused into the uterine lumen during Days 15-5-21 of the oestrous cycle.
Materials and Methods

Materials
Tissue culture supplies were purchased from Grand Island Biological Co., Grand Island, NY, USA. A modified Eagle's minimum essential medium (MEM, Gibco custom formula #86-5007) was prepared according to procedures described previously (Malayer et al, 1988 After harvesting the supernatant, precipitates were resuspended in 20 ml 20 mM-Tris-HCl pH 8-2 and the SAS precipi¬ tation procedure repeated. Supernatants from the second procedure were pooled with supernatants from the original precipitation. This material was buffered with lOmM-acetate pH 50 containing 1 mM-ethylene-diaminetetraacetic acid (EDTA), 0-7 mg pepstatin-A/1, 0-5 mg leupeptin/1 and 0-02% (w/v) NaN3 and dialysed (M, cut-off = 6000-8000) against 8 changes of 4-litre volumes of 10 mM-acetate buffer (pH 50) containing 1 mM-EDTA, 0-2 mM-PMSF, 0-7 mg pepstatin-A/1 and 002% NaN3. Supernatants were dialysed further against two changes of 6-litre volumes of 20 mMTris-HCl pH8-2 with 1 mM-EDTA, 0-7 mg pepstatin-A/1, 0-5 mg leupeptin/1 and 002% NaN3. After dialysis, the material was adjusted to a pH of 8-2 by addition of 1 M-NaOH in preparation for CM-Sepharose column chromatography. Because of the influx of water due to osmotic pressure differences in initial dialysis steps, volume of the material was approximately doubled during the dialysis process.
Ion exchange chromatography. All buffers used for ion exchange chromatography contained a cocktail of protease and bacterial growth inhibitors composed of 1 mM-EDTA, 0-7 mg pepstatin-A/1, 0-5 mg leupeptin/1, and 002% (w/v) NaNj. Supernatants from SAS precipitation were passed over a 2-6 cm 3-6 cm CM-Sepharose column equilibrated in 20 mM-Tris-HCl pH 8-2. Bound proteins were eluted subsequently using 20 mM-Tris-HCl pH 8-2 containing 1 MNaCl. Material not binding to the column was further processed by passage through two DEAE columns (2-6cm 3-6cm) pre-equilibrated with lOmM-Tris pH8-2 and attached in series. After washing extensively with 20 mM-Tris-HCl pH 8-2, bound proteins were eluted from each of the two DEAE columns separately, using 0-2 msodium phosphate buffer pH 7-9. First, one column volume of buffer was run through each column and flow stopped for a period of 2 h. Column flow was then continued and fractions pooled based upon presence of radioactivity. Pooled fractions were concentrated from 161 ml to Confirmation of purity. Aliquants of bovine serum albumin (BSA; 20 pg), bCSP (100 pg) and purified bTP-1 (16 pg) were concentrated and desalted using AMICON 10 ultrafiltration devices (AMICON, Danvers, MA, USA) and evaluated for purity using two dimension SDS-polyacrylamide gel electrophoresis (2-D SDS-PAGE). Proteins in the gels were identified by silver staining (Wray et al, 1981) . Immunoblotting was also carried out to identify immunoreactive bTP-1 in the purified array of proteins. Purified bTP-1 complex was separated by 2-D SDS-PAGE (8 pg/gel) and electrophoretically transferred to nitrocellulose (0-2 pm; Schleicher & Schuell, Keene, NH, USA). Blots were stained for 5 min to identify protein standards using 005% (w/v) amido black in methanol:acetic acid:water (40: 10:50, by vol.) and destained for 2 min in the same solvent. Blots were then washed briefly with water and placed in blocking buffer (10 mM-Tris-HCl pH 7-4 containing 2% (w/v) gelatin, 015 M-NaCl, 001% (v/v) Tween 20 and 002% (w/v) sodium azide) for 8 h. Subsequently, blots were incubated for 2 h with rabbit antiserum to oTP-1 (diluted 1:100) or normal rabbit serum (NRS; diluted 1:100). Both sera were diluted in incubation buffer (10 mM-Tris-HCl pH containing 1% (w/v) gelatin, 0-15M-NaCl, 001% (v/v) Tween 20 and 002% (w/v) sodium azide). Blots were rinsed with water, washed in incubation buffer twice for 30 min and then incubated with 20 ml 125I-labelled Protein A (1 106c.p.m./ml incubation buffer; prepared as described by Hansen & Newton, 1988 ) for 1 h. Blots were then washed extensively with incubation buffer and allowed to dry. Autoradiography was then performed using Kodak XAR-film and enhancing screens for visualization of immunoreactive protein bands.
Other procedures
Polyacrylamide gel electrophoresis. One-dimensional and two-dimensional sodium dodecyl sulphate polyacrylamide gel electrophoresis (1-D and 2-D SDS-PAGE), were performed as described elsewhere (Laemmli, 1970; Roberts et al, 1984; Malayer et al, 1988) .
Protein determination. Protein concentrations were determined by the BCA protein assay using BSA as the standard (Smith et al, 1985) .
Preparation of materials for intrauterine infusion. All materials were prepared in 0-2 M-NaP04 buffer pH 7-4 with added penicillin (lOO U/ml) and streptomycin (100 pg/ml). Bovine serum albumin was prepared at a concentration of 1-5 mg per 213 ml for infusion. Bovine conceptus proteins (« = 22 culture equivalents) were dialysed extensively against 10 mM-NaP04 pH 7-4 containing penicillin/streptomycin and then concentrated as described previously using Aquacide II. Sodium phosphate (to a concentration of 0-2 m), BSA and penicillin/streptomycin were added to the concentrate and pH adjusted to 7-4. Infusion doses for bCSP contained 0-75 mg bCSP and 0-75 mg BSA in a volume of 2-13 ml. Purified bTP-1 was prepared as a solution of 35 pg bTP-1 and 1-465 mg BSA in 213 ml. The BSA was added as a carrier for bTP-1 to approximate total protein mass produced during a 24 h period by a conceptus (Knickerbocker et al, 1986b) , to provide a protein pool to minimize destruction of bTP-1 by endogenous uterine proteases, and to provide a carrier molecule comparable to that used in the BSA control group. All samples were frozen at -70°C until time of intrauterine infusion.
Animal preparations. Cyclic, non-lactating Jersey cows (N = 9) were assigned randomly to BSA (control), bCSP or bTP-1 treatment groups and prepared for surgical placement of uterine catheters as described by Knickerbocker et al (1986b) (Macmillan et al, 1988) . Cows were allowed access to dirt lot twice daily (08:00 and 20:00 h) for 30 min from Day 15 until 24 h after the last animal was detected in oestrus for observation of oestrus. At this time, all intrauterine catheters were cleaned, withdrawn from the body cavity as far as possible by gentle traction, cut and allowed to pass into the body cavity. Animals were then maintained on pasture until observed in oestrus.
Radioimmunoassay of plasma hormones. Progesterone concentrations in heparinized plasma samples were measured with an assay system described by Knickerbocker et al (1986b) . With antiserum dilution of 1:40 000, sensitivity of the assay (100 or 200 µ samples) was 31-2 pg per tube. Intra-and interassay coefficients of variation were 711% and 13-41%, respectively.
Heparinized plasma samples from the posterior vena cava were assayed for PGF by procedures described by Knickerbocker et al. (1986c) for unextracted samples. The assay was modified to use an antibody supplied and characterized by Kennedy (1985) ; cross-reactivities of the PGF-2u antiserum were described previously by Gross et al (1988b) . Cross-reactivity of the PGF-2u antiserum for PGF-la was 94%, and so results of assays performed with this antiserum are referred to as PGF activity. Unextracted plasma samples of 200 pi were assayed for PGF. Sensitivity of the assay procedure was 10 pg (i.e. 50pg/ml) with an antibody dilution of 1:5000. Accuracy of the procedure for unextracted plasma was characterized by measuring known quantities of exogenous PGF added to 200 pi plasma (from cattle treated with an inhibitor to cyclo-oxygenase; Guilbault et al, 1984) at concentrations of 10-5000 pg per tube [y = 18-0 + I06x;y = amount of PGF measured (pg/0-2 ml), and = amount of PGF added (pg/0-2 ml), R2 = 0-98], A quantitative linear displacement curve was achieved. Tests for homogeneity of regression between this curve and the standard curve indicated that the curves were parallel. The intra-and interassay coefficients of variation were 10-6% and 18-5%, respectively.
Statistical analysis
Data for progesterone concentrations in plasma were analysed using the General Linear Models procedure of the Statistical Analysis System (SAS Institute Incorporated, 1985) Fig. 4 ). The proportion of counts recovered from Fractions 41-45 (corresponding to where bTP-1 elutes) ranged from 20 to 22%, while low-molecular weight products (Fractions 46-50) comprised 22-28% of the radioactivity. The discrepancy between h.p.l.c. and electrophoretic analysis probably reflects the fact that the low molecular-weight products are lost during fixation steps of electrophoresis.
Purification
It was determined in preliminary experiments that bTP-1 is extremely sensitive to proteolytic cleavage. As monitored by h.p.l.c. gel filtration, radiolabelled proteins in fractions corresponding to bTP-1 complex decreased when conceptus culture supernatants were stored for several days at 4°C (data not shown). A mixture of protease inhibitors containing 1 mM-EDTA, 0-7 mg pepstatin-A/1 and either 0-5 mg leupeptin/1 or 0-2 mM-PMSF was effective in inhibiting proteolytic cleavage of proteins during storage and purification procedures carried out at 4°C.
The first step of the purification procedure was saturated ammonium sulphate (SAS) precipi¬ tation of proteins. Adding SAS to a final concentration of 50% (v/v) resulted in a majority of the bTP-1 complex remaining in solution while several other proteins, including some with mole¬ cular weights similar to bTP-1, were precipitated (Fig. 2) (Fig. 3) . The region corresponding to bTP-1 (Fractions 46-48) also contained a protein species at an Mr of~45 000. The bTP-1 complex generally eluted in 3-5 fractions and 3-4 of these were pooled for preparing infusâtes.
Purity and yield of b TP-1
A total of 1-5 mg purified bTP-1 was obtained through the processing of 73 culture equivalents containing 138-7 mg total protein. This represents a yield of 11% (i.e. 20 µg bTP-1 per culture equivalent). Purity of bTP-1 was assessed by 2-D SDS-PAGE and silver staining (Fig. 4) . Ten protein species could be visualized (Fig. 4a ) including three at MT 22 000, 5 at MT 24 000 and 2 at Mr 26 000. This compares closely with results of Helmer et al (1987) in which the immunologically reactive components of the bTP-1 complex were first described. As shown in Fig. 4(b) and else¬ where (Dunbar, 1987) , components of the sample loading buffer stained with silver; to ascertain purity of bTP-1, it was therefore necessary to compare electrophoretograms of bTP-1 with those of loading buffer only. The only protein species detected by silver staining in the purified bTP-1 preparation that was not the result of non-specific staining was a minor contaminant migrating as Fig. 2 . Fluorograph of electrophoretogram of bCSPs subjected to 40 or 50% saturated ammonium sulphate (SAS) precipitation. Lanes 1, 3, 4 and 5 represent material from bCSP found in the supernatant and Lanes 2, 6, 7 and 8 material in the precipitate. Total material found in supernatant (Lanes 1 and 3) and precipitates (Lanes 2 and 6) is shown. Supernatants and precipitates were immunoabsorbed with rabbit anti-oTP-1 antiserum (Lanes 4 and 7) or normal rabbit serum (Lanes 5 and 8).
BSA (compare Fig. 4a to 4b which represents a 2-D gel containing no protein). This may represent potential leaching of BSA from the pre-coated Zorbax GF 250 column. The bTP-1 preparation is designated as highly enriched bTP-1 due to the presence of BSA. Proteins present in the preparations of bCSP and BSA used for infusion are shown in Fig. 4 (c, d) .
Immunoblotting using anti-oTP-1 antiserum was performed to verify that the purified pro¬ teins were in fact bTP-1 (Fig. 5) . The array of proteins that cross-reacted with the antibody corresponded exactly with those identified by silver staining in the purified bTP-1 preparation (Fig.  4a) except that BSA did not react. More isoelectric species of the bTP-1 were identified as being immunoreactive in this study than those reported earlier (Helmer et al, 1987) . This may be due to enrichment of bTP-1 molecular components during purification that were not detectable by immunoprecipitation of bCSP as described earlier (Helmer et al, 1987) .
Effects of intrauterine infusions on oestrous cycle responses
Treatment of cyclic cows with highly enriched bTP-1 extended the interoestrous interval (Table 2) . Orthogonal contrasts were made comparing (1) BSA vs bCSP and bTP-1 treatment and (2) bCSP vs bTP-1 treatment for all responses. Interoestrous interval in which treatments were administered was greater (P < 0-04) for cows treated with bCSP and bTP-1 than for BSA-treated cows. The increase was due to a longer interoestrous interval for bTP-1-treated cows than for cows treated with bCSP (P < 005) or for BSA-treated cows. 
Progesterone profiles
Differences in CL lifespan between groups was examined by evaluating plasma progesterone profiles through a regression analysis that allowed treatment differences to be tested by homogeneity of regression analysis (Knickerbocker et al, 1986b) . Luteal phases were extended for bCSP and bTP-1 treatments compared to BSA-treated controls (P < 001; Fig. 6 ). This difference was due largely to an extension of the luteal phase of bTP-1-treated cows since these cows differed from bCSP-treated animals (P < 001).
Orthogonal contrasts comparing the interval from the pre-treatment oestrus to when progester¬ one fell below 1 ng/ml was greater (P < 01) for bCSP-and bTP-1-vs BSA-treated animals (18-5 and 240 vs 17-7 days, respectively); the interval was longer (P < 002) for cows treated with bTP-1 than for cows treated with bCSP. The period between when progesterone fell below 1 ng/ml and the post-treatment oestrus was not different between treatments (Table 2) . Similarly, post-treatment oestrous cycle lengths were not affected by treatments (Table 2) .
Prostaglandin profiles
Due to difficulties encountered with inserting and maintaining vena cava catheters, only 2 cows from each treatment group were sampled successfully. Components of variation in residual variances for each treatment include experimental error, but also sample to sample variation among the consecutive 25 15-min periods within and among the days for each of the cows. Residual variances for bTP-1-treated cows (19202) were lower than for bCSP-treated cows (326-42) and BSA-treated cows (719908). This was apparent when examining individual profiles of cows sampled on each day. The BSA-treated cows exhibited frequent elevations of plasma PGF concen¬ trations, whereas most samples for bTP-1-and bCSP-treated animals were undetectable in the radioimmunoassay (Fig. 7) . Due to heterogeneity of variances, data were transformed before statistical analysis by using the reciprocal of PGF values. Transformation reduced heterogeneity of variances, but variances were still significantly different (P < 005). Analysis of variance to test Fig. 4 . Silver-stained, two-dimensional electrophoretograms of (a) highly enriched bTP-1 com¬ plex (16 pg), (b) sample buffer without protein, (c) total conceptus proteins (100 pg) and (d) bovine serum albumin (20 pg). treatment means (PGF) indicated that the BSA (971 + 9-79 ng/ml) versus bTP-1 (53-3 + 113 ng/ ml) + bCSP (56-8 + 2-69 ng/ml) contrast approached significance (P < 0-1). Concentrations of PGF for BSA-treated cows were nearly twice that of bTP-1-and bCSP-treated cows. The cycle extension brought about by bTP-1 treatment appears to be due to a direct effect of increasing length of the luteal phase, as shown by an increase in the period from pretreatment oestrus to when progesterone fell below 1 ng/ml. This extension was not due to an increase in the follicular phase because the period from when progesterone fell below 1 ng/ml to post-treatment oestrus was not different between treatment groups. Rescue of the CL by bTP-1 is most likely the result of altered PGF-2a release from the uterus since bTP-1-treated cows had altered patterns of PGF-2cx concentrations in vena cava plasma. It has been well established that luteolysis in cattle occurs via secretion of PGF-2a from the uterus (Wolfenson et al, 1987) . There is an attenuation of PGF release from cultured Gross et al, 1988a) or perfused (Gross et al, 1988b ) endometrial tissues of pregnant cattle when compared to cyclic cattle. Furthermore, Knickerbocker et al (1986a, b) have demonstrated that cattle which had received intrauterine in¬ fusions of bCSP had extended CL function and attenuated PGF secretion and release in response to an oestradiol challenge. The exact mechanism whereby bTP-1 attenuates PGF release is not known. It has been demonstrated that endometrial inhibitors to prostaglandin synthesizing enzymes exist and their activity is increased during pregnancy (Basu & Kindahl, 1987; Gross et al, 1988c) . Furthermoree, bCSP induces prostaglandin inhibitor activity (Gross et al, 1988a) . Recently, Helmer et al (1989) demonstrated that bTP-1 reduced secretion of PGF from expiants of cyclic cattle probably via induction of an endogenous prostaglandin synthesis inhibitor(s). It is therefore possible that bTP-1 acts as an antiluteolysin by inducing inhibitors to prostaglandin synthesizing enzymes in the uterus. It is evident that similar mechanisms for preventing luteal regression exist in the sheep and cow. The antiluteolytic molecules responsible for this event, bTP-1 and oTP-1, have extensive amino acid sequency homology with each other and interferon-a (Imakawa et al, 1989) and regulate PGF-2a secretion. Nevertheless, there are some differences between sheep and cattle in the dynamics of PGF-2a secretion in early pregnancy (see Thatcher et al, 1986 , for review) with secretion being much more suppressed in cattle than sheep. The ability of bTP-1 to induce an intracellular endometrial prostaglandin synthetase inhibitor (Helmer et al, 1989) may account for this suppression in early pregnancy. Whether oTP-1 has a similar effect has not been tested. However, Salamonsen et al (1988) demonstrated that oTP-1 suppresses PGF-2a and PGE-2 secretion from cultured endometrial cells of sheep.
